Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.